Skip to main content
. 2003 Jul;89(7):715–721. doi: 10.1136/heart.89.7.715

Table 1.

Actuarial survival and occurrence of valve related events after 10 and 20 years in patients receiving a Bjork-Shiley or porcine prosthesis

All patients
10 years 20 years p Value*
Survival
All survivors
    Bjork-Shiley valve 58.7 (3.0) 25.0 (2.7) 0.39
    Porcine valve 53.6 (3.1) 22.6 (2.7)
Survivors with original prosthesis intact
    Bjork-Shiley valve 55.7 (3.1) 23.5 (2.6) <0.0001
    Porcine valve 42.6 (3.0) 6.7 (1.6)
Survivors without a major event
    Bjork-Shiley valve 47.0 (3.1) 13.8 (2.2) 0.0007
    Porcine valve 37.3 (3.0) 4.8 (1.4)
Valve related events
Reoperation
    Bjork-Shiley valve 7.1 (1.8) 12.2 (2.5) <0.0001
    Porcine valve 27.0 (3.3) 67.8 (5.0)
Bleeding: all episodes
    Bjork-Shiley valve 15.3 (2.7) 55.6 (5.5) 0.007
    Porcine valve 7.5 (2.2) 43.6 (8.6)
Bleeding: major episodes
    Bjork-Shiley valve 11.7 (2.4) 40.7 (5.4) 0.008
    Porcine valve 4.9 (1.8) 27.9 (8.4)
Embolism: all episodes
    Bjork-Shiley valve 19.4 (2.8) 36.6 (4.6) 0.77
    Porcine valve 25.1 (3.3) 37.9 (6.5)
Embolism: major episodes
    Bjork-Shiley valve 8.3 (1.9) 13.9 (3.1) 0.68
    Porcine valve 9.0 (2.2) 13.6 (4.9)
Endocarditis
    Bjork-Shiley valve 3.8 (1.4) 7.5 (2.6) 0.60
    Porcine valve 4.6 (1.6) 10.3 (4.6)

Values are % (mean (SEM)).

*p Value from log rank tests, Bjork-Shiley v porcine valves at 20 years.